CA
FOLD

Calton & Associates’s Amicus Therapeutics FOLD Stock Holding History

Calton & Associates’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-10,011
Closed -$142K – 213
2023
Q4 		$142K Buy
+10,011
New +$114K 0.06% 232
2023
Q3 		– Sell
-10,923
Closed -$137K – 163
2023
Q2 		$137K Sell
10,923
-441
-4% -$5.23K 0.06% 202
2023
Q1 		$126K Sell
11,364
-1,023
-8% -$12.6K 0.06% 223
2022
Q4 		$151K Sell
12,387
-40
-0.3% -$450 0.06% 265
2022
Q3 		$129K Sell
12,427
-4,138
-25% -$46.1K 0.07% 199
2022
Q2 		$177K Sell
16,565
-955
-5% -$7.86K 0.1% 222
2022
Q1 		$165K Buy
+17,520
New +$164K 0.05% 334
2021
Q1 		– Sell
-9,178
Closed -$212K – 410
2020
Q4 		$212K Sell
9,178
-2,252
-20% -$46.1K 0.04% 353
2020
Q3 		$161K Sell
11,430
-1,193
-9% -$17.4K 0.03% 324
2020
Q2 		$190K Sell
12,623
-90
-0.7% -$1.1K 0.04% 311
2020
Q1 		$117K Buy
12,713
+1,656
+15% +$15.7K 0.03% 286
2019
Q4 		$108K Buy
11,057
+412
+4% +$3.77K 0.02% 350
2019
Q3 		$85K Buy
+10,645
New +$116K 0.02% 338

Other funds holding FOLD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Calton & Associates's FOLD Position: Q1 2024 in Review

Calton & Associates sold out of Amicus Therapeutics (FOLD) in Q1 2024, closing a stake of 10,011 shares — an estimated $142K sold.

Calton & Associates first reported a position in FOLD in Q3 2019 and held it in 13 quarters. The position peaked at $212K in Q4 2020. 254 funds tracked by Wall St. Rank hold FOLD as of Q1 2024.

  • Calton & Associates reported no remaining Amicus Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Calton & Associates sold 10,011 Amicus Therapeutics shares in Q1 2024, an estimated $142K.
  • Calton & Associates first reported a position in Amicus Therapeutics in Q3 2019 and held it in 13 quarters.
  • Calton & Associates's Amicus Therapeutics position peaked at $212K in Q4 2020.
  • 254 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2024.

Based on Calton & Associates's 13F filing for Q1 2024, filed 16 Apr 2024.